Bank of America’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $552M | Buy |
|
|||||
2025
Q1 | $524M | Sell |
|
|||||
2024
Q4 | $767M | Buy |
|
|||||
2024
Q3 | $626M | Sell |
|
|||||
2024
Q2 | $832M | Buy |
|
|||||
2024
Q1 | $725M | Buy |
|
|||||
2023
Q4 | $315M | Sell |
|
|||||
2023
Q3 | $596M | Sell |
|
|||||
2023
Q2 | $891M | Sell |
|
|||||
2023
Q1 | $946M | Buy |
|
|||||
2022
Q4 | $916M | Buy |
|
|||||
2022
Q3 | $688M | Sell |
|
|||||
2022
Q2 | $693M | Buy |
|
|||||
2022
Q1 | $549M | Buy |
|
|||||
2021
Q4 | $489M | Sell |
|
|||||
2021
Q3 | $755M | Sell |
|
|||||
2021
Q2 | $843M | Sell |
|
|||||
2021
Q1 | $987M | Buy |
|
|||||
2020
Q4 | $799M | Sell |
|
|||||
2020
Q3 | $827M | Buy |
|
|||||
2020
Q2 | $772M | Sell |
|
|||||
2020
Q1 | $637M | Buy |
|
|||||
2019
Q4 | $452M | Buy |
|
|||||
2019
Q3 | $343M | Buy |
|
|||||
2019
Q2 | $298M | Buy |
|
|||||
2019
Q1 | $288M | Sell |
|
|||||
2018
Q4 | $239M | Sell |
|
|||||
2018
Q3 | $496M | Buy |
|
|||||
2018
Q2 | $309M | Buy |
|
|||||
2018
Q1 | $273M | Buy |
|
|||||
2017
Q4 | $263M | Buy |
|
|||||
2017
Q3 | $225M | Sell |
|
|||||
2017
Q2 | $210M | Buy |
|
|||||
2017
Q1 | $138M | Buy |
|
|||||
2016
Q4 | $96.1M | Sell |
|
|||||
2016
Q3 | $207M | Buy |
|
|||||
2016
Q2 | $163M | Sell |
|
|||||
2016
Q1 | $187M | Buy |
|
|||||
2015
Q4 | $104M | Buy |
|
|||||
2015
Q3 | $87.2M | Sell |
|
|||||
2015
Q2 | $128M | Buy |
|
|||||
2015
Q1 | $96.2M | Buy |
|
|||||
2014
Q4 | $66.2M | Buy |
|
|||||
2014
Q3 | $50.7M | Sell |
|
|||||
2014
Q2 | $52M | Sell |
|
|||||
2014
Q1 | $50.1M | Buy |
|
|||||
2013
Q4 | $31.1M | Sell |
|
|||||
2013
Q3 | $39.9M | Buy |
|
|||||
2013
Q2 | $29.6M | Buy |
|